Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction
The current role of AI is summarized across the peptide cancer vaccine development pipeline, from neoantigen discovery and epitope prioritization to prediction of peptide–HLA binding, antigen presentation, and T-cell receptor recognition, and the application of modern computational frameworks.